24-week Trial Comparing GSK573719/GW642444 With GW642444 and With Tiotropium in Chronic Obstructive Pulmonary Disease

PHASE3CompletedINTERVENTIONAL
Enrollment

846

Participants

Timeline

Start Date

March 1, 2011

Primary Completion Date

April 1, 2012

Study Completion Date

April 24, 2012

Conditions
Pulmonary Disease, Chronic Obstructive
Interventions
DRUG

GSK573719/GW642444 125/25

125/25 mcg once-daily

DRUG

GSK573719/GW642444 62.5/25

62.5/26 mcg once-daily

DRUG

GW642444

25 mcg once-daily

DRUG

tiotropium bromide

18 mcg once-daily

Trial Locations (97)

10700

GSK Investigational Site, México

10717

GSK Investigational Site, Berlin

12157

GSK Investigational Site, Berlin

12203

GSK Investigational Site, Berlin

13086

GSK Investigational Site, Berlin

14467

GSK Investigational Site, Potsdam

17027

GSK Investigational Site, Pietra Ligure (SV)

19460

GSK Investigational Site, Phoenixville

20121

GSK Investigational Site, Milan

21029

GSK Investigational Site, Vinnytsia

21049

GSK Investigational Site, Tradate (VA)

22299

GSK Investigational Site, Hamburg

23229

GSK Investigational Site, Richmond

23606

GSK Investigational Site, Newport News

27100

GSK Investigational Site, Pavia

29340

GSK Investigational Site, Gaffney

29615

GSK Investigational Site, Greenville

29678

GSK Investigational Site, Seneca

29732

GSK Investigational Site, Rock Hill

30029

GSK Investigational Site, Nîmes

30033

GSK Investigational Site, Decatur

30159

GSK Investigational Site, Hanover

30173

GSK Investigational Site, Hanover

32720

GSK Investigational Site, DeLand

32822

GSK Investigational Site, Orlando

33170

GSK Investigational Site, Pordenone

33603

GSK Investigational Site, Tampa

35037

GSK Investigational Site, Marburg

35216

GSK Investigational Site, Birmingham

44093

GSK Investigational Site, Nantes

44100

GSK Investigational Site, Guadalajara

44147

GSK Investigational Site, Dortmund

44263

GSK Investigational Site, Dortmund

45200

GSK Investigational Site, Zapopan

49027

GSK Investigational Site, Dnipropetrovsk

49074

GSK Investigational Site, Dnipropetrovsk

56124

GSK Investigational Site, Pisa

57702

GSK Investigational Site, Rapid City

61037

GSK Investigational Site, Kharkiv

61124

GSK Investigational Site, Kharkiv

63003

GSK Investigational Site, Clermont-Ferrand

63301

GSK Investigational Site, Saint Charles

69035

GSK Investigational Site, Zaporizhia

70378

GSK Investigational Site, Stuttgart

71100

GSK Investigational Site, Foggia

73103

GSK Investigational Site, Oklahoma City

74889

GSK Investigational Site, Sinsheim

76018

GSK Investigational Site, Ivano-Frankivsk

78229

GSK Investigational Site, San Antonio

80339

GSK Investigational Site, Munich

83099

GSK Investigational Site, Donetsk

83100

GSK Investigational Site, Avellino

87108

GSK Investigational Site, Albuquerque

90402

GSK Investigational Site, Nuremberg

91052

GSK Investigational Site, Erlangen

92117

GSK Investigational Site, San Diego

95043

GSK Investigational Site, Simferopol

95123

GSK Investigational Site, Catania

96049

GSK Investigational Site, Bamberg

97448

GSK Investigational Site, Saint-Pierre

100184

GSK Investigational Site, Ploieşti

115446

GSK Investigational Site, Moscow

185019

GSK Investigational Site, Petrozavodsk

194354

GSK Investigational Site, Saint Petersburg

300310

GSK Investigational Site, Timișoara

390039

GSK Investigational Site, Ryazan

394018

GSK Investigational Site, Voronezh

410018

GSK Investigational Site, Saratov

410028

GSK Investigational Site, Saratov

600252

GSK Investigational Site, Bacau

634001

GSK Investigational Site, Tomsk

664005

GSK Investigational Site, Irkutsk

672000

GSK Investigational Site, Chita

29406-7108

GSK Investigational Site, Charleston

00144

GSK Investigational Site, Rome

07760

GSK Investigational Site, Mexico City

Lima 27

GSK Investigational Site, Lima

GSK Investigational Site, San Isidro

Lima 11

GSK Investigational Site, Jesus Maria

Lima 41

GSK Investigational Site, San Borja

Lima 32

GSK Investigational Site, San Miguel

Lima 33

GSK Investigational Site, Santiago de Surco

Callao 2

GSK Investigational Site, Callao

Lima 1

GSK Investigational Site, Lima

80-405

GSK Investigational Site, Gdansk

97-540

GSK Investigational Site, Gidle

31-023

GSK Investigational Site, Krakow

42-700

GSK Investigational Site, Lubliniec

81-741

GSK Investigational Site, Sopot

87-800

GSK Investigational Site, Włocławek

41-800

GSK Investigational Site, Zabrze

011794

GSK Investigational Site, Bucharest

Unknown

GSK Investigational Site, Yaroslavl

03680

GSK Investigational Site, Kiev

GSK Investigational Site, Kyiv

01114

GSK Investigational Site, Kyiv

03038

GSK Investigational Site, Kyiv

Sponsors

Lead Sponsor

All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY